Correlation Between TG Therapeutics and PharmChem
Can any of the company-specific risk be diversified away by investing in both TG Therapeutics and PharmChem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TG Therapeutics and PharmChem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TG Therapeutics and PharmChem, you can compare the effects of market volatilities on TG Therapeutics and PharmChem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TG Therapeutics with a short position of PharmChem. Check out your portfolio center. Please also check ongoing floating volatility patterns of TG Therapeutics and PharmChem.
Diversification Opportunities for TG Therapeutics and PharmChem
-0.83 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between TGTX and PharmChem is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding TG Therapeutics and PharmChem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PharmChem and TG Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TG Therapeutics are associated (or correlated) with PharmChem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PharmChem has no effect on the direction of TG Therapeutics i.e., TG Therapeutics and PharmChem go up and down completely randomly.
Pair Corralation between TG Therapeutics and PharmChem
Given the investment horizon of 90 days TG Therapeutics is expected to under-perform the PharmChem. In addition to that, TG Therapeutics is 8.42 times more volatile than PharmChem. It trades about -0.09 of its total potential returns per unit of risk. PharmChem is currently generating about -0.21 per unit of volatility. If you would invest 310.00 in PharmChem on September 24, 2024 and sell it today you would lose (5.00) from holding PharmChem or give up 1.61% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 95.24% |
Values | Daily Returns |
TG Therapeutics vs. PharmChem
Performance |
Timeline |
TG Therapeutics |
PharmChem |
TG Therapeutics and PharmChem Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with TG Therapeutics and PharmChem
The main advantage of trading using opposite TG Therapeutics and PharmChem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TG Therapeutics position performs unexpectedly, PharmChem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmChem will offset losses from the drop in PharmChem's long position.TG Therapeutics vs. Fate Therapeutics | TG Therapeutics vs. Sana Biotechnology | TG Therapeutics vs. Caribou Biosciences | TG Therapeutics vs. Arcus Biosciences |
PharmChem vs. Mesabi Trust | PharmChem vs. Nutanix | PharmChem vs. Ggtoor Inc | PharmChem vs. Aquagold International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |